Clinical Trials Logo
  1. Home
  2. Cancer-Related Fatigue
  3. NCT06435091

REBECCA-3 Study, Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data — REBECCA-3  

Cancer Related Fatigue Clinical Trial

Official title:
REBECCA-3 Study, Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data

Clinical Trial Summary

The overall aim of the REBECCA project is to exploit the potential of "real-world data" to support clinical research and improve existing clinical workflow. The primary aim of the REBECCA-3 study is to use multi-source "real-world data" to monitor the quality of life (QoL) of prostate cancer patients who are affected by cancer-related fatigue during and after treatment. This is to investigate whether the REBECCA monitoring is accepted by male patients and can be used within various forms of cancer. Study design: 40 prostate cancer patients that undergo radiology and/or chemotherapy treatment will be included at the time of diagnosis. After end of primary treatment, the patients will receive a smartwatch, and have to download a REBECCA patient app on their mobile and a PC plug-in on their PC so that we can monitor their QoL for 4 months. In addition to collecting digital QoL parameters through the REBECCA-system, patient-reported QoL measures will also be collected through standardized PROMs and self-evaluation forms. Further, biological samples (blood, urine, and faeces) are collected at three time points of the study (i.e., at the time of: diagnosis, completed treatment, and 4 months post treatment), to investigate immunologic biomarkers, DNA methylation patterns and microbiota for assessment of new biological and prognostic information related to the development of cancer-related fatigue in prostate cancer patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06435091
Study type Observational
Source Helse Stavanger HF
Contact Kjersti Tjensvoll, PhD
Phone 004747809206
Email tjensvollk@gmail.com
Status Recruiting
Phase
Start date May 2024
Completion date May 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT01564394 - Body Mind Training Project N/A
Recruiting NCT03730298 - American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients N/A
Completed NCT01926678 - Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer Survivors Phase 2
Active, not recruiting NCT06120595 - REBECCA-2 Study: Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data N/A
Terminated NCT01990066 - Home Based Exercise Program for Elderly Cancer Patients N/A
Not yet recruiting NCT04235946 - Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer Remission N/A
Active, not recruiting NCT02846389 - Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer N/A
Not yet recruiting NCT01881516 - Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF） Phase 2
Recruiting NCT03773003 - Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME) N/A
Not yet recruiting NCT05696275 - Using Combine Walking and Elastic Band to Decrease Fatigue N/A
Completed NCT01440621 - Modafinil in Cancer Related Fatigue Phase 3
Recruiting NCT02127268 - Thymosin-α1 in Cancer-Related Fatigue Phase 3